Illumina's Verinata Reports Non-invasive Verifi Prenatal Test2 Ccorrectly Detects Aneuploidies Across All Test Samples

By: Benzinga
Illumina, Inc. (NASDAQ: ILMN ) today announced Verinata Health, an Illumina company, published additional peer-reviewed data1 showing that Verinata's non-invasive verifi® prenatal test2 correctly detects aneuploidies across all
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.